In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $61.67, marking a +2.24% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.59%. On the other hand, the ...

Researchers at Duke University used CRISPR technologies to discover previously unannotated stretches of DNA in the "dark ...

Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat ...

A team led by scientists at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and ...

Science and medicine are incredibly amazing. Thanks to modern science and medicine, we now have lifespans far beyond our Dark ...

New enhancer protein expands IDT's market-leading portfolio of HDR reagents, empowering cell and gene therapy developers to ...

That’s why a team from UC San Diego in La Jolla set out with Yale University researchers to develop a new system for gene ...

Cas9, genome editing has been revolutionized by the ability to introduce targeted genetic changes with unprecedented ...

Gene editing in plants remains challenging, with the traditional non-homologous end-joining (cNHEJ) repair pathway often ...

The CRISPR gene editing system holds tremendous promise. It has already revolutionized biomedical research and ... | Genetics And Genomics ...

The first DARWIN policy brief focuses on the analytical detection of new genomic techniques (NGTs) in food and feed. Genome-editing technologies, ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $60.62, moving -2.38% from the previous trading session. The stock fell short of the S&P 500, which registered a loss of 0.55% for ...